Gaik-Siew Ch’ng
Dados Biográficos
| ID | 7876722 |
|---|---|
| NOME | Gaik-Siew Ch’ng |
| PRENOMES | Gaik-Siew |
| SOBRENOME | Ch’ng |
| ASSINATURA | CH’NG G |
| AFILIAÇÕES | Hospital Kuala Lumpur |
| ORCID | 0000-0001-7595-1618 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 2 |
| TOTAL DE CITAÇÕES | 0 |
| OBRAS COMO AUTOR | 2 |
| OBRAS COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2021 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2021 |
| ÍNDICE H | 0 |
Genetic Testing for Cancer Risk
With the increasing number of cancer cases worldwide, genetic testing for familiar cancers seems inevitable, yet little is known on population interest and the monetary value for cancer genetic risk information. The current study aimed to determine the willingness to undergo and pay for cancer genetic testing among the Malaysian population. A self-administered questionnaire was distributed to cancer patients and their family members in the oncolo…
Cost-Effectiveness of Colorectal Cancer Genetic Testing
Colorectal cancer (CRC) remains the second leading cause of cancer-related deaths worldwide. Approximately 3-5% of CRCs are associated with hereditary cancer syndromes. Individuals who harbor germline mutations are at an increased risk of developing early onset CRC, as well as extracolonic tumors. Genetic testing can identify genes that cause these syndromes. Early detection could facilitate the initiation of targeted prevention strategies and su…
Sem obras proeminentes nesta página.
Genetic Testing for Cancer Risk
With the increasing number of cancer cases worldwide, genetic testing for familiar cancers seems inevitable, yet little is known on population interest and the monetary value for cancer genetic risk information. The current study aimed to determine the willingness to undergo and pay for cancer genetic testing among the Malaysian population. A self-administered questionnaire was distributed to cancer patients and their family members in the oncolo…
Cost-Effectiveness of Colorectal Cancer Genetic Testing
Colorectal cancer (CRC) remains the second leading cause of cancer-related deaths worldwide. Approximately 3-5% of CRCs are associated with hereditary cancer syndromes. Individuals who harbor germline mutations are at an increased risk of developing early onset CRC, as well as extracolonic tumors. Genetic testing can identify genes that cause these syndromes. Early detection could facilitate the initiation of targeted prevention strategies and su…
Cancer (2 obras) · Genetic factors in colorectal cancer (2 obras) · Genetic testing (2 obras) · Internal Medicine (2 obras) · Medicine (2 obras) · Activity-based costing (1 obra) · Biology (1 obra) · BRCA gene mutations in cancer (1 obra) · Cancer Genomics and Diagnostics (1 obra) · Colorectal cancer (1 obra)